{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:04:46Z","timestamp":1793271886489,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03636-1","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:15:45Z","timestamp":1738109745000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Remimazolam for procedural sedation in gastrointestinal endoscopy: real-life, single center observational study"],"prefix":"10.1186","volume":"25","author":[{"given":"Conigliaro","family":"Rita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pig\u00f2","family":"Flavia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiazzo","family":"Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grande","family":"Giuseppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russo","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cocca","family":"Silvia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lupo","family":"Marinella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marocchi","family":"Margherita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsico","family":"Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sculli","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertani","family":"Helga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"3636_CR1","first-page":"929","volume":"13","author":"WK Rogers","year":"2010","unstructured":"Rogers WK, McDowell TS. Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and\/or anesthesia in day-case surgical and non-surgical procedures. IDrugs. 2010;13:929\u201337.","journal-title":"IDrugs"},{"key":"3636_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2334\/josnusd.21-0051","volume":"63","author":"S Oka","year":"2021","unstructured":"Oka S, Satomi H, Sekino R, et al. Sedation outcomes for remimazolam, a new benzodiazepine. J Oral Sci. 2021;63:209\u201311.","journal-title":"J Oral Sci"},{"key":"3636_CR3","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1213\/ANE.0b013e31823f0c28","volume":"115","author":"LJ Antonik","year":"2012","unstructured":"Antonik LJ, Goldwater DR, Kilpatrick GJ, et al. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. safety, efficacy, and basic pharmacokinetics. Anesth Analg. 2012;115:274\u201383.","journal-title":"Anesth Analg."},{"key":"3636_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.gie.2018.04.2351","volume":"88","author":"DK Rex","year":"2018","unstructured":"Rex DK, Bhandari R, Desta T, et al. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2018;88:427\u201337.","journal-title":"Gastrointest Endosc"},{"key":"3636_CR5","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.2147\/DDDT.S339535","volume":"15","author":"X Liu","year":"2021","unstructured":"Liu X, Ding B, Shi F, et al. The efficacy and safety of remimazolam tosilate versus etomidate-propofol in elderly outpatients undergoing colonoscopy: a prospective, randomized, single-blind, non-inferiority trial. Drug Des Devel Ther. 2021;15:4675\u201385.","journal-title":"Drug Des Devel Ther"},{"key":"3636_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.dld.2020.10.039","volume":"53","author":"DK Rex","year":"2021","unstructured":"Rex DK, Bhandari R, Lorch DG, et al. Safety and efficacy of remimazolam in high risk colonoscopy: a randomized trial. Dig Liver Dis. 2021;53:94\u2013101.","journal-title":"Dig Liver Dis"},{"key":"3636_CR7","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/EJA.0000000000001715","volume":"39","author":"Y Yao","year":"2022","unstructured":"Yao Y, Guan J, Liu L, et al. Discharge readiness after remimazolam versus propofol for colonoscopy: a randomised, double-blind trial. Eur J Anaesthesiol. 2022;39:911\u20137.","journal-title":"Eur J Anaesthesiol"},{"key":"3636_CR8","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.gie.2015.08.062","volume":"83","author":"DJ Pambianco","year":"2016","unstructured":"Pambianco DJ, Borkett KM, Riff DS, et al. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2016;83:984\u201392.","journal-title":"Gastrointest Endosc"},{"key":"3636_CR9","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1213\/ANE.0000000000000548","volume":"120","author":"KM Borkett","year":"2015","unstructured":"Borkett KM, Riff DS, Schwartz HI, et al. A Phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy. Anesth Analg. 2015;120:771\u201380.","journal-title":"Anesth Analg"},{"key":"3636_CR10","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/jgh.15188","volume":"36","author":"SH Chen","year":"2021","unstructured":"Chen SH, Yuan TM, Zhang J, et al. Remimazolam tosilate in upper gastrointestinal endoscopy: A multicenter, randomized, non-inferiority, phase III trial. J Gastroenterol Hepatol. 2021;36:474\u201381.","journal-title":"J Gastroenterol Hepatol"},{"key":"3636_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1213\/ANE.0000000000000740","volume":"121","author":"O Visnjevac","year":"2015","unstructured":"Visnjevac O, Davari-Farid S, Lee J, et al. The effect of adding functional classification to ASA status for predicting 30-day mortality. Anesth Analg. 2015;121:110\u20136.","journal-title":"Anesth Analg"},{"key":"3636_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2024.10.007","author":"R Conigliaro","year":"2024","unstructured":"Conigliaro R, Pig\u00f2 F, Gottin M, et al. Bertani, Safety of endoscopist-directed nurse-administered sedation in an Italian referral hospital: An audit of 2 years and 19,407 procedures. Dig Liver Dis. 2024. https:\/\/doi.org\/10.1016\/j.dld.2024.10.007.","journal-title":"Dig Liver Dis"},{"key":"3636_CR13","doi-asserted-by":"publisher","first-page":"e0171233","DOI":"10.1371\/journal.pone.0171233","volume":"12","author":"X Cao","year":"2017","unstructured":"Cao X, Yumul R, Elvir Lazo OL, et al. A novel visual facial anxiety scale for assessing preoperative anxiety. PLoS ONE. 2017;12:e0171233.","journal-title":"PLoS ONE."},{"key":"3636_CR14","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1136\/bmj.2.5920.656","volume":"2","author":"MA Ramsay","year":"1974","unstructured":"Ramsay MA, Savage TM, Simpson B, et al. Controlled sedation with alphaxalone-alphadolone. BMJ. 1974;2:656\u20139.","journal-title":"BMJ"},{"key":"3636_CR15","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1213\/00000539-197011000-00020","volume":"49","author":"JA Aldrete","year":"1970","unstructured":"Aldrete JA, Kroulik D. A postanesthetic recovery score. Anesth Analg. 1970;49:924\u201334.","journal-title":"Anesth Analg"},{"key":"3636_CR16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/bja\/42.6.535","volume":"42","author":"DD Brice","year":"1970","unstructured":"Brice DD, Hetherington RR, Utting JE. A simple study of awareness and dreaming during anaesthesia. Br J Anaesth. 1970;42:535\u201342.","journal-title":"Br J Anaesth"},{"key":"3636_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12871-022-01713-6","volume":"22","author":"J Guo","year":"2022","unstructured":"Guo J, Qian Y, Zhang X, et al. Remimazolam tosilate compared with propofol for gastrointestinal endoscopy in elderly patients: a prospective, randomized and controlled study. BMC Anesthesiol. 2022;22:180.","journal-title":"BMC Anesthesiol"},{"key":"3636_CR18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00540-021-02934-8","volume":"35","author":"K Tsurumi","year":"2021","unstructured":"Tsurumi K, Takahashi S, Hiramoto Y, et al. Remimazolam anaphylaxis during anesthesia induction. J Anesth. 2021;35:571\u20135.","journal-title":"J Anesth"},{"key":"3636_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40981-022-00508-5","volume":"8","author":"S Uchida","year":"2022","unstructured":"Uchida S, Takekawa D, Kitayama M, et al. Two cases of circulatory collapse due to suspected remimazolam anaphylaxis. JA Clin Rep. 2022;8:18.","journal-title":"JA Clin Rep."},{"key":"3636_CR20","doi-asserted-by":"publisher","first-page":"e12167","DOI":"10.1002\/anr3.12167","volume":"10","author":"M Yamaoka","year":"2022","unstructured":"Yamaoka M, Kuroda K, Matsumoto N, et al. Remimazolam anaphylaxis confirmed by serum tryptase elevation and skin test. Anaesth Rep. 2022;10:e12167.","journal-title":"Anaesth. Rep."},{"key":"3636_CR21","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1016\/j.bja.2022.07.047","volume":"129","author":"KM Kim","year":"2022","unstructured":"Kim KM, Lee, Bang JY, Choi BM, et al. Anaphylaxis following remimazolam administration during induction of anaesthesia. Br J Anaesth. 2022;129:e122\u20134.","journal-title":"Br J Anaesth."},{"key":"3636_CR22","doi-asserted-by":"publisher","DOI":"10.1213\/XAA.0000000000001616","volume":"16","author":"Y Hasushita","year":"2022","unstructured":"Hasushita Y, Nagao M, Miyazawa Y, et al. Cardiac Arrest Following Remimazolam-Induced Anaphylaxis: A Case Report. AA Pract. 2022;16:e01616.","journal-title":"AA Pract"},{"key":"3636_CR23","first-page":"99","volume":"23","author":"X Hu","year":"2023","unstructured":"Hu X, Tang Y, Fang X. Laryngeal edema following remimazolam-induced anaphylaxis: A rare clinical manifestation. BMcAnesthesiol. 2023;23:99.","journal-title":"BMcAnesthesiol"},{"key":"3636_CR24","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.3390\/medicina59111915","volume":"59","author":"S Lee","year":"2023","unstructured":"Lee S, Park J, Kim NH, et al. Remimazolam Anaphylaxis during Induction of General Anesthesia Confirmed by Provocation Test-A Case Report and Literature Review. Medicina (Kaunas). 2023;59:1915.","journal-title":"Medicina (Kaunas)"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03636-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03636-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03636-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:15:47Z","timestamp":1738109747000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03636-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3636"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03636-1","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"1 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the principles of the Declaration of Helsinki. the study was reviewed and approved in 2024, December 23th (protocol 432\/2023\/OSS*\/AOUMO) by the Ethical Committee (Comitato Etico Area Vasta Emilia Nord, Modena, Italy). A signed informed consent was obtained for sedation before any clinical investigation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}